Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells

Por Michel, Loren, Diaz-Rodriguez, Elena, Narayan, Gopeshwar, Hernando, Eva, Murty, Vundavalli V. V. S., Benezra, Robert
Publicado em 2004

Risk Factors for and Pre-medications to Prevent Cetuximab-Induced Infusion Reactions in Patients with Squamous Cell Carcinoma of the Head and Neck

Por Touma, Waseem, Koro, Sami S., Ley, Jessica, Wildes, Tanya M., Michel, Loren, Tao, Yu, Adkins, Douglas
Publicado em 2014

A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

Por Adkins, Douglas, Ley, Jessica, Dehdashti, Farrokh, Siegel, Marilyn J, Wildes, Tanya M, Michel, Loren, Trinkaus, Kathryn, Siegel, Barry A
Publicado no Cancer Med (2014)

Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Por Ley, Jessica, Mehan, Paul, Wildes, Tanya M., Thorstad, Wade, Gay, Hiram A., Michel, Loren, Nussenbaum, Brian, Trinkaus, Kathryn, Adkins, Douglas
Publicado em 2013

Phase I Trial of Palbociclib, a Selective Cyclin Dependent Kinase 4/6 Inhibitor, in Combination with Cetuximab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Car...

Por Michel, Loren, Ley, Jessica, Wildes, Tanya M., Schaffer, András, Robinson, Anthony, Chun, Se-Eun, Lee, Wooin, Lewis, James, Trinkaus, Kathryn, Adkins, Douglas
Publicado no Oral Oncol (2016)

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo

Por Lombardo, Ylenia, Filipović, Aleksandra, Molyneux, Gemma, Periyasamy, Manikandan, Giamas, Georgios, Hu, Yunhui, Trivedi, Pritesh S., Wang, Jayson, Yagüe, Ernesto, Michel, Loren, Coombes, R. Charles
Publicado em 2012

RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis

Por Saporita, Anthony J., Chang, Hsiang-Chun, Winkeler, Crystal L., Apicelli, Anthony J., Kladney, Raleigh D., Wang, Jianbo, Townsend, R. Reid, Michel, Loren S., Weber, Jason D.
Publicado em 2011

nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma

Por Adkins, Douglas, Ley, Jessica, Michel, Loren, Wildes, Tanya M., Thorstad, Wade, Gay, Hiram A., Daly, Mackenzie, Rich, Jason, Paniello, Randal, Uppaluri, Ravindra, Jackson, Ryan, Trinkaus, Kathryn, Nussenbaum, Brian
Publicado no Oral Oncol (2016)

Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma

Por Wang, Jianbo, Zhang, Kaihua, Grabowska, Dorota, Li, Aimin, Dong, Yiyu, Day, Ryan, Humphrey, Peter, Lewis, James, Kladney, Raleigh D., Arbeit, Jeffrey M., Weber, Jason D., Chung, Christine H., Michel, Loren S.
Publicado em 2011

Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck

Por Schell, Amy, Ley, Jessica, Wu, Ningying, Trinkaus, Kathryn, Wildes, Tanya Marya, Michel, Loren, Thorstad, Wade, Gay, Hiram, Lewis, James, Rich, Jason, Diaz, Jason, Paniello, Randal C, Nussenbaum, Brian, Adkins, Douglas R
Publicado no Cancer Med (2015)

Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC

Por Zhang, Kaihua, Jones, Lamont, Lim, Sora, Maher, Christopher A., Adkins, Douglas, Lewis, James, Kimple, Randall J., Fertig, Elana J., Chung, Christine H., Herrlich, Andreas, Ellis, Matthew J., Van Tine, Brian A., Michel, Loren S.
Publicado no Oncotarget (2014)

PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies

Por Michel, Loren S., Dyroff, Samantha, Brooks, Frank J., Spayd, Katherine J., Lim, Sora, Engle, Jacquelyn T., Phillips, Sharon, Tan, Benjamin, Wang-Gillam, Andrea, Bognar, Christopher, Chu, Wenhua, Zhou, Dong, Mach, Robert H., Laforest, Richard, Chen, Delphine L.
Publicado no Radiology (2017)

A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas

Por Bean, Gregory R, Kremer, Jeff C, Prudner, Bethany C, Schenone, Aaron D, Yao, Juo-Chin, Schultze, Matthew B, Chen, David Y, Tanas, Munir R, Adkins, Douglas R, Bomalaski, John, Rubin, Brian P, Michel, Loren S, Van Tine, Brian A
Publicado no Cell Death Dis (2016)

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Por Li, Shunqiang, Shen, Dong, Shao, Jieya, Crowder, Robert, Liu, Wenbin, Prat, Aleix, He, Xiaping, Liu, Shuying, Hoog, Jeremy, Lu, Charles, Ding, Li, Griffith, Obi L., Miller, Christopher, Larson, Dave, Fulton, Robert S., Harrison, Michelle, Mooney, Tom, McMichael, Joshua F., Luo, Jingqin, Tao, Yu, Goncalves, Rodrigo, Schlosberg, Christopher, Hiken, Jeffrey F., Saied, Laila, Sanchez, Cesar, Giuntoli, Therese, Bumb, Caroline, Cooper, Crystal, Kitchens, Robert T., Lin, Austin, Phommaly, Chanpheng, Davies, Sherri R., Zhang, Jin, Kavuri, Megha Shyam, McEachern, Donna, Dong, Yi Yu, Ma, Cynthia, Pluard, Timothy, Naughton, Michael, Bose, Ron, Suresh, Rama, McDowell, Reida, Michel, Loren, Aft, Rebecca, Gillanders, William, DeSchryver, Katherine, Wilson, Richard K., Wang, Shaomeng, Mills, Gordon B., Gonzalez-Angulo, Ana, Edwards, John R., Maher, Christopher, Perou, Charles M., Mardis, Elaine R., Ellis, Matthew J.
Publicado em 2013